LINDA LOGANG: Open Payments
NPI 1730469081 · MONTCLAIR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 10 payments from 6 companies in 2025. Trend: 2023 $1,352 · 2024 $395 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $476 |
| Vanda Pharmaceuticals Inc. | 2 | $246 |
| Neurocrine BioSciences, Inc. | 1 | $130 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $87 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: VRAYLAR, FANAPT, INGREZZA, Qelbree, Auvelity, REXULTI.
Industry payments across NJ — which companies pay providers there.
